1,721,395 research outputs found
Bellvitge Biomedical Research Institute: research centre for cancer, neurosciences and translational medicine
Get PDFL’Institut de Recerca Biomèdica de Bellvitge (IDIBELL), establert l’any 2004 a l’Hospitalet de Llobregat, al sud de Barcelona, té el seu focus en càncer, neurociències i medicina translacional. Els seus socis locals són l’Hospital Universitari de Bellvitge Hospital (HUB) I l’Hospital de Viladecans, que són part de l’Institut Català de la Salut (ICS), l’Institut Català d’Oncologia (ICO), la Universitat de Barcelona (UB) i l’Ajuntament de l’Hospitalet de Llobregat. L’any 2009 es van convertir en un dels cinc primers instituts d’investigació sanitària acreditat per l’Institut de Salut Carlos III. Els investigadors de l’IDIBELL fan recerca bàsica, translacional, clínica i epidemiològica de qualitat que està organitzada en 3 àrees i 9 programes. Aquesta recerca té com a objectiu una aplicació efectiva dels avenços científics en la prevenció, diagnòstic, pronòstic i tractament dels problemes de Salut alhora que promouen la innovació en la recerca sanitària. The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center for cancer, neurosciences and translational medicine established in 2004 in L’Hospitalet de Llobregat, south of Barcelona. Its local partners are the Bellvitge University Hospital (HUB) and the Viladecans Hospital, both part of the Catalan Institute of Health (ICS), the Catalan Institute of Oncology (ICO), the University of Barcelona (UB) and the town council of L’Hospitalet de Llobregat. In 2009, it became one of the first five Spanish research centers accredited as a health research institute by the Carlos III Institute of Health. IDIBELL also carries out high-level basic, epidemiological, translational and clinical research though three areas and nine research programs, aiming at an effective translation of scientific advances into the prevention, diagnosis, prognosis and treatment of health problems and promoting innovation in health research.Keywords: IDIBELL, Cancer, Neuroscience, Translational Medicine, Bellvitge
Identification of Key Molecules Involved in the Protection of Vultures Against Pathogens and Toxins
No full textGoing Beyond Counting First Authors in Author Co-citation Analysis
Get PDFThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
Get PDF“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Appropriate Similarity Measures for Author Cocitation Analysis
Get PDFWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Aeromonas species: an opportunistic enteropathogen in patients with inflammatory bowel diseases? A single center cohort study
No full textThe role of Aeromonas species as an enteropathogen in patients with and without inflammatory bowel disease (IBD) is still debated. The aim was to explore the significance of positive Aeromonas stool cultures in IBD and patients without IBD.sponsorship: T. Lobaton was kindly supported by a grant from the Bellvitge Biomedical Research Institute, Barcelona (IDIBELL); I. Hoffman receives lecture fee from Nutricia, Mead Johnson, Takeda and consultancy from Mead Johnson; S. Vermeire is a clinical investigator of the Funds for Scientific Research, Flandres (FWO) Belgium and receives financial support for research from UCB Pharma, MSD and Abbvie, lecture fees from Abbvie, Merck, Ferring, UCB Pharma and Centocor, and consultancy from UCB Pharma, AstraZeneca, Ferring, Abbvie, Merck, Ferring, Shire and Pfizer; M. Ferrante receives financial support for research from Janssen Biologics, lecture fees from Merck, Tillotts, Ferring, Abbvie and consultancy from Abbvie, Merck, Janssen Biologics; J. Verhaegen receives lecture fee from Bayer; G. Van Assche receives financial support for research from Abbvie and Ferring, lecture fees form Janssen-Cilag, Merck and Abbvie and consultancy from PDL BioPharma, UCB Pharma, Sanofi-Aventis, Abbvie, Ferring, Novartis, Biogen Idec, Janssen Biologics, NovoNordisk, Zealand Pharma A/S, Millenium/Takeda, Shire, Novartis and BMS. (Bellvitge Biomedical Research Institute, Barcelona (IDIBELL), Nutricia, Mead Johnson, Takeda, UCB Pharma, MSD, Abbvie, Merck, Ferring, Centocor, Janssen Biologics, Tillotts, Bayer, Janssen-Cilag)status: Publishe
Dispelling the Myths Behind First-author Citation Counts
Get PDFWe conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
Steps for iterating design-implement experiences into a CDIO course
No full textThis paper describes how a particular form of iterative design-implement experiences were driven in the fourth-year Advanced Project in Science and Telecommunications Technology of the Degree in Sciences and Telecommunication Technologies taught at the Escola Tècnica Superior d'Enginyeria de Telecomunicació de Barcelona (Telecom BCN), in which students were faced with the incremental development of an innovative mirroring tool for facial paralysis rehabilitation. This work was done in the research framework established by Telecom BCN, Bellvitge University Hospital and Bellvitge Biomedical Research Institute
(IDIBELL).Peer ReviewedPostprint (published version
- …
